Intelligence Unit
Special Reports
Special Events
Subscribe
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
Clot-Busting Stroke Drug Could Save $200M Annually
Treating mild strokes with an intravenous tissue plasminogen activator (tPA), a drug usually reserved for more severe strokes, could save costs by reducing the disabling after-effects of a stroke, researchers say.